小青龙汤加减治疗支气管哮喘外寒内饮证疗效分析

The Clinical Curative Effect of Modified Xiao Qinglong Decoction in Treating Bronchial Asthma Waihan Neiyin Syndrome

目的:通过西药和西药联合小青龙汤治疗支气管哮喘的疗效对比,评价小青龙汤对支气管哮喘的治疗作用。方法:将60名患者随机分为对照组和治疗组,对照组给予西药常规治疗(抗炎、抗过敏、平喘、必要时吸氧等),治疗组在西医治疗基础上辨证给予小青龙汤加减,疗程均为10d,并进行为期3个月的长期随访。在治疗前后进行外周血嗜酸性粒细胞计数(EO)、免疫球蛋白E(Ig E)检测,结合肺功能(PEF、FEV1)等评价其疗效,并采用哮喘控制问卷(ACQ)评价远期疗效。结果:治疗组各项疗效指标均优于对照组,差异具有统计学意义(P<0.05)。结论:西药联合小青龙汤能显著改善支气管哮喘的临床症状及实验室检测指标,其疗效优于单纯西药组。

Objective： To evaluate the effect of modified Xiao Qinglong decoction in treating bronchial asthma Waihan Neiyin syndrome. Methods： 60 patients were randomly divided into control group and treatment group; control group given conventional western medicine therapy; the treatment group on the basis of western medicine dialectical to give Xiao Qinglong decoction; a course of 10 days; and long-term follow-up for 3 months. In before and after treatment for peripheral eosinophil count （EO）; immunoglobulin E （IgE）detection; combined with lung function （PEF; FEV1）to evaluate its efficacy; and USES the questionnaire of asthma control （ACQ）evaluate the long-term curative effect. Results： the treatment group curative effect index were superior to control group; the difference is statistically significant （P〈0.05）. Conclusion： western medicine in combination with Xiao Qinglong decoction can significantly improve the clinical symptom and laboratory test index of bronchial asthma; its curative effect is superior to pure western medicine group.